论文部分内容阅读
制药用精细化学品可定义为用于制药业以生产药用物质或有效成分的精细化学品。因而制药用精细化学品包括一批数量巨大、在分子复杂性、价格或数量方面要求颇为不同的产品。目前,全球每年用于制药业的精细化学品价值在500亿美元以上,达到了制药行业总营业额的13%～14%。在过去十年里,由于医疗保健的成本居高不下,发达国家的政府和保险公司都希望制药企业能够降低药品价格。而发展中
Pharmaceutical fine chemicals can be defined as fine chemicals used in the pharmaceutical industry to produce medicinal substances or active ingredients. Thus, pharmaceutical fine chemicals include a large number of products that require quite different molecular complexity, price or quantity. Currently, the global annual fine chemicals used in the pharmaceutical industry is worth over 50 billion U.S. dollars, reaching 13% to 14% of the total revenue of the pharmaceutical industry. In the past decade, due to the high cost of health care, developed country governments and insurance companies all hope that pharmaceutical companies can lower the price of medicines. And developing